U.S. markets closed

Inspire Medical Systems, Inc. (INSP)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
171.16+4.53 (+2.72%)
At close: 4:00PM EDT
Sign in to post a message.
  • R
    Ross
    Will this newest news article on the "Commercialization of INSP in Japan" have any impact on the share price? What does "Commercialization" mean anyway? UNFI was already approved for use in Japan and some studies were done there quite a while ago.
  • 8
    8man
    Dropped below support
  • 8
    8man
    I see it collecting dust in a couple of institutions I call on. I think they are front selling product . SP does not seem to represent what I see in my region . But with the institutional ownership don't think it matter ..at least now
  • 8
    8man
    How many people in Japan have refractory sleep apnea?? Let's see I got Sumo wrestlers on my list and then....
  • M
    Mo
    Shorts - Please provide a list of your other short positions, so I can buy those stocks.
    Bullish
  • S
    SongBird
    Weird stock? No earnings or PE but high price? Growth is ok but no where it needs to be for a stock price like this??? I don’t get it????
  • Y
    Yahoo Finance Insights
    Inspire Medical Systems is down 7.26% to 210.09
  • t
    trany
    INSP keeps going up isn't unfathomable because it has negative earnings every single quarter. The best thing people can say about this stock is it lose money this quarter less than last quarter and stock goes up 10 dollars. Can any one explain for me why? beside hedge funds manipulate stock to keep high price?
    Bearish
  • G
    Gerald
    Has this finally stopped dropping?
  • V
    Valuation Skeptic
    looks like strong current supports at $224/share. Analysts were very positive coming out of the quarterly earnings call. Management provided a strong earning growth forecast.
    Neutral
  • B
    Big Bear
    I still do not understand how this company is valued so high? should be 50% lower than where it is priced now. I bought Aug 230 put but do recognize more than 700 March 250 calls traded on 2/19 against 15 OI. Do not know if it is bullish or someone protecting their position in case stock drops.
  • t
    trany
    This is the 3rd quarter result of INSP:
    Revenue 35.8 MILL (less than sale of 10 Walmarts in one day)
    Loss -0.39
    Open 42 new centers and total 370 centers
    Open 7 new sell territories and total 98 sell territories
    Well, well, well! with 370 centers and 98 sell territories, INSP 3rd revenue is 38.5 Mil less than sale of 10 Walmart in one day and funny part is stock price increases 15 dollars to 215.
    HOW DO YOU THINK?
    Bearish
  • R
    Ross
    Is there a metric that makes this a valid $230/share stock in this market? Is it worth the risk? I don't think so, and I love this company and product. Will I be able to, at some point in the near future, be able to buy this at a substantial discount to this price? Heck YES, I think. Will there be a market correction at some point in the next year that will make this stock a buy? Again, I believe it is pending. So, unless I am swing trading, this is a stock to watch, but stay out of for now as it is one that could destroy a portfolio (at this point in the market cycle) just as quickly as it made many wealthy.
  • R
    Rob
    What do you think, AL ? Great Conference call tonight! 4th Quarter highest analyst estimate of $14.9M vs $16.6M actual - 66% higher than 2017.
    2018 Full year highest analyst estimate was $49M versus $50.6 actual a 77% increase over 2017.
    Europe revenue 46% higher.
    Sales in Japan expected to start this year.
    Gross margins of 81% for 2018 vs 78.9% for 2017 !! @ 80% expected for 2019.
    Blue Cross Insurance approvals for Patients will ramp up 2nd half of this year; and are NOT included in 2019 Guidance.
    FDA pediatric studies continuing, hoping for FDA approval.
    High BMI patient studies continuing, hoping for FDA approval.
    Any other competitor will be two years behind.
    Developing Inspire Cloud for physicians, and Phone APP, so patients and doctors can tract products.
  • 8
    8man
    I give up on this institutional ego play. Numbers don't make sense at all. But Tutes will move it where they want till final realization comes
    Home that market just not that big.
    Buh bye
  • V
    Valuation Skeptic
    STRONG SELL / OVERVALUED. This week will be a financial disaster for any $INSP longs. Ugly bloodbath this week with earning reporting. Possible 50% downside risk.
    Bearish
  • V
    Valuation Skeptic
    INSP will miss earnings expectations, valuation has put the share price under severe pressure. Forecasting $180/share post earnings release, could possibly be worse depending if key Institutional investors decide to book profits and move on. It will be interesting.
    Bearish
  • S
    Steve
    Here you go MAJOR SELL OFF.. DOWN 24% in after hour. Happy to be holding 7000 share SHORT for the 52 week high. More selling tomorrow... with minimal volume trading this will fall FAST,
  • R
    Realtastic
    Non-essential product in covid-19 times, too expensive in normal times. Last quarter sales tanked. Since then, CFO & CCO rightfully sold shares. Still overpriced with 37x TEV/ Rev, no earnings and increased losses due to increased sales YoY. What's the long thesis here?
    Bearish
  • t
    trany
    This is a typical hype case (or scam) of Wal Street magicians. I traded for more than 26 years but still don't understand how a company with 4.5 Bil market cap with 95 Mil revenue and a loss every single quarter but stock price keeps going up and up?
    Bearish